Randox Supports Family Business Week 21st-25th November 2022
Randox Supports Family Business Week 21st-25th November 2022
The theme for Family Business Week 2022 is ‘Celebrating Our Place in the World’. It will highlight the central role family firms play in shaping and supporting their local communities, economy and natural environment. The campaign is led by the IFB, the voice of the UK’s family business sector and supported by NatWest.
In honour of this week, Randox would like to share our family business history:
In April 1982, Randox Laboratories was founded by Dr Peter Fitzgerald from a converted chicken house off Randox Road, near Crumlin in Antrim, where he had grown up.
FitzGerald started out using equipment discarded by university research labs but, through decades of hard work and innovation, slowly built the company into a market leader. Randox Laboratories is now the largest diagnostics company from the UK with over 40 years of experience operating in over 145 countries.
The Covid-19 pandemic saw Randox Laboratories on the front line for testing for the Covid-19 virus across the UK and Ireland. After downloading the virus genetic sequence in January 2020, Randox were able to quickly develop a test. This meant that by March 2020, Randox were provided with a contract by Public Health England to test as part of the National Testing Program.
After investing in 78,000 sq ft of laboratory testing space and hiring additional staff, Randox were able to process over 25million PCR tests as part of the National Testing Program as well as private testing allowing a return to work and travel.
Expanding into the travel market and providing an essential service to people to travel to see loved ones after years in isolation. There was a realisation that the future landscape for healthcare has changed forever. People have become used to testing themselves. People want to know the status of their health and are actively taking control of their health and wellbeing.
Randox Health has recently made significant investment to deliver our preventative, personalised testing packages across the nation and are opening up to 25 Randox Health clinics in the short term – In England, Ireland, Scotland, and Wales. Randox Health clinics focus on the provision of cost-effective, timely and accurate testing to identify risk to health, improve clinical diagnoses and promote preventative healthcare. Our aim is to improve and save lives through early detection of disease.
The growing network of clinics provide easy access for millions of people to a new Randox range of diagnostic tests, including for cancer, vitamin deficiencies, hormone imbalances, allergies and key health concerns including heart, liver, and kidney conditions. Real time insights on current and future health risks are provided to empower clients to make simple dietary and lifestyle changes giving them the power to extend their lives.
Randox clinics also offer a new range of comprehensive diagnostic programmes, including the ‘EveryMan’ and ‘EveryWoman’ 12-month programmes/full body ‘MOTs’. These enable up to 150 data points linked to key health areas to be measured during each visit with a personalised health plan summarising results provided. Repeat tests and consultation will be arranged six months after the initial test, included in the testing programme prices, which start at £295 per person.
Randox would like to congratulate the IT Department on their Belfast Telegraph IT Awards Win!
The Randox IT department were delighted to win the IT Team or Department of the Year award sponsored by Continu. Described as the ‘clear winner’ by Belfast Telegraph, Randox IT won the award due to their hard work and dedication during the Covid-19 pandemic.
The awards took place on Friday at the MAC Theatre in Belfast and was hosted by comedian Neil Delamere. Northern Ireland’s incredible IT industry was showcased displaying their great achievements and their significant, positive impact on the local economy.
In the past 12 months, Randox IT department transformed the cutting-edge systems and facilities created during the pandemic to allow customers to take control of their health through preventative testing. Randox IT were very much at the forefront of innovation and continued to develop and enhance our offerings, processing 27 million covid results in total. Furthermore, expanding into the travel market and providing an essential service to people who could finally travel to see loved ones after years in isolation.
The team’s disruptive approach to development has allowed Randox to respond quickly in an ever-evolving situation and introduce a full end-to-end testing process facilitating multiple key stages such as, logistics, registration, accessioning, sample processing and results reporting.
At the beginning of 2022, there was a realization that the future landscape for healthcare has changed forever. People want to know the status of their health and are actively taking control of their health and wellbeing. Through these innovate solutions developed by Randox IT in the fight against covid, the team have focused on the future vision of healthcare and developed solutions for customers to test themselves, in clinic or at home, for areas such as heart health, Thyroid health, STI, Vit and Minerals as well as our most popular packages of Everyman, Everywomen, Signature, Every Athlete.
This has only been possible due to the dedication and expertise of the IT team who released a new version of the Randox Health customer platform, which provides each customer with a customized view of their health. Customers have key insights to their health data allowing them to track their health.
Randox would like to congratulate Eileen Nixon on her retirement!
Eileen has been a valuable member of Randox for 32 years beginning her career here in November 1990. She describes how remarkable the growth of Randox has been. From a smaller scale business back in 1990 to now the largest diagnostics company from the UK.
On Thursday morning, we celebrated Eileen’s achievements and fond memories during her time in our Manufacturing Division, within the Packing Team. The room was filled with Eileen’s colleagues, many of whom had worked with Eileen for well over 20 years. Eileen has been a great member of the Randox team and will be sorely missed.
We wish Eileen good health and every happiness for her retirement.
Randox Laboratories, the largest diagnostics company from the UK, are proud to announce a $3.8m CAD seed round with Verv Technologies.
Randox Laboratories are the lead investor for Verv Technologies, who are focused on creating the first of its kind consumer-oriented, affordable, high-quality blood chemistry analyser with disposable tests for home use, that will help individuals measure a wide range of analytes (i.e., cholesterol, vitamin levels, hormones). With over 40 years of diagnostic experience, Randox Laboratories are focused on investment into technologies to improve health for all.
Dr. Peter Fitzgerald, Managing Director of Randox Laboratories shared, “Randox has a global lens on the development of new technologies. We have a shared vision and belief in Verv’s unique, highly differentiated microfluidics approach to creating scalable, high-quality, low-cost blood testing technology for healthcare consumers. We anticipate a great journey ahead, in partnership with Verv.
Jeff Sutton, Founder and President of Verv Technologies describes, “We are thrilled to have Randox as a major investor in Verv to help propel us to commercial readiness and the opportunity to work with the original Founder and Managing Director of Randox, Dr. Peter Fitzgerald, who will join Verv’s Board of Directors. We aim to create great value for health-conscious consumers.”
Randox and Verve share a commitment to transform testing on a global scale for the benefit of healthcare consumers.
Diagnostic giant Randox Health partners with Revolut to improve health awareness among the financial apps 6 million UK users
Randox Health, the leading UK diagnostics and personalised health company is partnering with financial super-app Revolut to provide its 6 million UK customers with an exclusive 15% discount on all Randox Health testing programmes, promoting preventative healthcare amongst a wider range of people than ever.
Keeping track of your personal health isn’t always easy to do with the pressures of work and social life in the way. However, with so much to enjoy in life, protecting your personal health is crucial. Randox Health provides personalised health insights to empower clients to make simple dietary and lifestyle changes giving them the power to extend their lives.
As the UK’s largest healthcare diagnostics company, Randox Health’s network of nationwide high-street clinics, which will total 20 by the end of 2022, will provide easy access for Revolut’s 20 million users to a new range of diagnostic tests. These can identify early signs of vitamin deficiencies, hormone imbalances, allergies and key health concerns including heart, liver and kidney conditions and are priced from just £41.
Randox Health clinics also offer other comprehensive diagnostic programmes, including its ‘EveryMan’ and ‘EveryWoman’ 12-month programmes. These enable up to 150 data points linked to key health areas to be measured during the initial visit, the repeat test and consultation six months later, with a personalised health plan summarising results provided.
The discount is currently available to all Revolut customers via their Revolut app which is already revolutionising financial services available to consumers.
Alexander Rusak the Vice President of Sales at Randox Health says:
“Randox Health is proud to be partnering with Revolut with this exclusive discount. Having a regular review of your personalised health values is vital to understanding and maintaining good health. Access to regular health screening will allow clients to actively take control of their health to prevent or delay disease. Revolut will provide Randox Health with a platform to connect with a growing number of those who are interested in owning their health.”
Jose Marira Barreiros Cardoso, Revolut’s Key Partner Developer says:
“Revolut are excited about the new collaboration with Randox Health. We believe that financial and personal health should go hand in hand. Through this collaboration we wish to connect our customers and allow them the opportunity to invest in their personal health. Randox Health enables conversations for people to change how their view their personal health, exactly like how we have changed the way people approach their banking.”
For press enquiries please contact Ellen Watson in the Randox PR team: firstname.lastname@example.org
27th July 2022: Randox response to the Public Accounts Committee (PAC) report, ‘Government’s contracts with Randox Laboratories Ltd’
A spokesperson for Randox said:
“The PAC report is deeply flawed and wrong in assumptions it makes and the conclusions it draws about Randox.
“As the UK’s largest diagnostic company, with four decades of experience, over 2,000 professional staff on hand at the start of the pandemic and more than £350m of prior investment in diagnostic and engineering innovation, Randox was uniquely situated to respond to the national need when COVID-19 emerged in early 2020.
“In supporting the UK’s urgent requirement for coronavirus testing Randox reacted with speed, efficiency and flexibility in delivering value. The company developed and built, in record time, the UK’s largest COVID-19 laboratories and testing services. It provided the Department of Health and Social Care with a PCR testing capacity at the time of greatest need, rising from 300 tests per day to 120,000 per day by January 2021.
“Altogether Randox processed over 25 million samples for UK’s National Testing Programme and in support of international travel for business and personal reasons. This played a crucial role in keeping vital elements of the UK economy functioning during lockdowns.
“In adapting to rapidly changing DHSC and Department of Transport requirements, Randox delivered unique value to the government, the national economy and to individuals.
“At no stage, either during its deliberations or in its preparation of this report, did the PAC make any contact whatsoever with Randox. Consequently many elements of its report relating to Randox are false, based as they are, on wrong and unchecked assumptions about the company. For that reason, they and any publications arising from them are the subject of a legal complaint.”
“The issues the report raises around internal DHSC record keeping are clearly a matter for DHSC”
For all media enquiries, please contact Ian Monk on email@example.com or +44 7970 026072 / + 44 203 011 1933
Randox in the media
We will be exhibiting at AACC Annual Scientific Meeting and Clinical Lab EXPO 2022!
Come visit us at The McCormick Place Convention Center in Chicago from 26th July-28th July 2022.
Visit booth #1419 where we will be discussing innovative diagnostic products and solutions, as well as showcasing our pioneering technologies!
Our Extensive Product Range
With 40 years of experience in the industry, we are experts in the field. Visit our website to find out more. Our Product Specialists Team will be available at booth #1419 to answer any questions, but why not plan ahead? Request a meeting with any of our Randox representatives and secure a time slot across the 5 day event.
Meet The Team
Click on the team member’s photo to request a meeting
Diagnostics and personalised health company Randox to deliver £10m investment for major UK research project Our Future Health
Randox, the Northern Ireland-based diagnostics and personalised health company, has today been announced as one of four new industry partners in the Our Future Health (OFH) programme, which will be the UK’s largest ever health research programme.
Randox will deliver a £10m investment in the programme, which will discover and develop new methods of prevention, early detection and treatment of diseases and health conditions.
The company is one of four new partners who will deliver a total of £40m to OFH. They join 10 additional life sciences companies that were previously announced as funding partners in January 2022. As well as its £10m investment, Randox will contribute its world-leading expertise to the programme. Its network of 20 High Street clinics, including those in Holywood and Crumlin, will also be available if required to test volunteers from across the UK taking part in the OFH project. The project aims to monitor the long-term health of 5 million volunteers in the coming years, starting this autumn.
Andrew Roddam, Chief Executive of OFH, said: “We are delighted to be announcing a further four industry partners for OFH, who together will provide an additional £40m to further our objective to develop new ways to prevent, detect and treatments enabling people to live healthier lives for longer. We welcome Randox as one of these partners, knowing their long-term commitment to diagnostics, and look forward to working with them in the months and years ahead.”
OFH has also joined with 16 health research charities, who have endorsed the pilot phase of the programme and are providing valuable support and experience.
Volunteers will be asked to complete an online health questionnaire, give their informed consent to link information from their healthcare records to OFH and donate a small blood sample.
Volunteers are also being asked to give their permission for OFH to contact them in the future to give them the opportunity to take part in follow-on research and to provide personal feedback about their health, should they wish to receive it.
Researchers from across the life sciences community, including academia, industry and the NHS, will be able to apply to study OFH resources as part of their crucial research to accelerate the discovery and development of innovative diagnostics and treatments.
Volunteers’ data will be de-identified and held in ‘trusted research environments’ that meet strict security criteria and an access board, which will include independent experts and members of the public, to ensure OFH resources are only used for health research in the public interest.
Randox Managing Director, Dr Peter FitzGerald said:
“Randox has been engaged from the very outset and is now excited to formally support this world-leading research project, both as a funding member and with our considerable expertise.
“With over 40 years of diagnostic experience, and extensive research capabilities, Randox knows that a personalised approach to the early detection and prevention of disease is not only critical to saving and extending life, but also to improving the quality of our lives. This project will further those critical goals. The ability for participants to receive feedback on their health from the project, and to engage with future research, also promotes Randox’s objective of greater individual ownership of health.
“Randox is committed to providing accessible and affordable testing to drive significant health improvements through the early detection and prevention of disease. ‘Our Future Health’ is perfectly aligned with that vision.”
For more information contact:
+44 (0) 7891525749
Want to know more?
We are attending EUROMEDLAB 2022!
Come visit us in Munich from 10th-14th April at EuroMedlab 2022!
We will be at stand 7 where you can discover how we are currently revolutionising healthcare with our innovative products!
Our Extensive Product Range
With 40 years of experience in the industry, we are experts in the field. Visit our website to find out more. Our Product Specialists Team will be available at Hall 3, Stand 218 to answer any questions, but why not plan ahead? Request a meeting with any of our Randox representatives and secure a time slot across the 3 day event.
Meet The Team
Our Product Specialists Team will be available to answer any questions, but why not plan ahead? Request a meeting by clicking on the team member’s photo to secure a dedicated time slot to talk with a Randox representative.
Molecular Product Specialist, Team Leader
Ben has been working at Randox for 5 years and during his time he has become an expert in the field of molecular diagnostics. Stop by our booth and discuss Qnostics, QCMD, Vivalytic, Discovery and more with Ben.
Sales Manager Slovakia
After study of General Biology at University of Matej Bel (Slovakia) Jana started working at RANDOX in the Sales Department Slovakia in July 2005. Continual business development with best possible effectiveness and profitability for company is my long-term key focus in RANDOX Slovakia. Sales projects contribute of all RANDOX product range including biochip array technology, molecular arrays.
Business Development Manager, Poland
Remy is the Business Development Manager for Poland and the Balkans (Croatia, Serbia, Macedonia, Bosnia), actively promoting the clinical product portfolio. Graduating from Edinburgh Napier University with a Biomedical Science degree and have been working in Randox sales department since September 2019.
European Sales Manager
Bryony Boyd is one of the Randox European Sales Managers for the clinical product portfolio. A biomedical science graduate from University of Ulster, Bryony has been actively promoting the Randox clinical portfolio to the Baltics, Austria, Slovenia, Greece, Cyprus and Switzerland. Her main focus is IQC, EQA, Rx Series, Vivalytic and Reagents.
Product Specialist, European Region
Heidi is the Randox Product Specialist for the European region. A Zoology graduate from Queen’s University Belfast, Heidi has actively been promoting the Randox clinical portfolio to the Nordics, BeNeLux, Albania, Moldova and Romania. Her main focus is IQC, EQA, Rx Series, Reagents and Vivalytic. Heidi has been working in Randox since 2019, firstly as a Technical Support Scientist and now as a Product Specialist in the sales department.
Business Development Manager, France
After a Master’s degree in BioEngineering and BioTechnologies in the Healthcare Industry, Diana has gained experience as Marketing and Sales Executive for more than 7 years in the medical & pharmaceutical field.
National Sales Manager , France
Alexander followed an International Business Administration bachelor and specialised in innovation management Master degree at the Rotterdam School of Management in the Netherlands. He moved into his first role within Randox as Sales Representative. After 2 successful years, he moved to a Sales Team Leader position and then to the National Sales Manager position. He is 100% dedicated to improving healthcare in France and in accompanying Randox in doing so worldwide.
International Sales Manager, South East Italy
Luciano has been working in Randox since March 2010 as sales consultant for south-east Italy. Dedicated to develop and follow customer for centre-south Italy. As Sales Manager, he is focused on QA, Reagents, Toxicology and molecular product. Luciano also has a private interest to organic farming dedicated to improving human nutrition.
International Sales Manager, Italy
Alessandro is an International Sales Manager with years of experience in drug testing monitoring and creating tailor-made solutions for laboratories, hospitals and government facilities.
Molecular Product Specialist
Rachel Forsythe began her career with Randox working as a Biochip Analyst and Extraction Scientist in the COVID Laboratories during the pandemic. Rachel is now working as a Molecular Product Specialist on a global scale. She also specialises in the Randox Point of Care analyser, the VeraSTAT for both clinical and veterinary as she studied Zoology in University.
Since joining the company in 2015, James has been part of the Quality Control Marketing team, promoting our range of Acusera controls, RIQAS EQA programmes and Acusera 247 data management software across the globe. He also has experience in the promotion and marketing of Qnostics and QCMD. More recently he has moved to a corporate role and now part of the team responsible for managing our advertising, events, marketing automations, sponsorships and more.
Martin is one of the clinical marketing team managers, promoting our diverse range of analysers including Chemistry, Immunoassay, Molecular and Point of Care. He also has experience in collaborative promotion and corporations with our business partners and distribution network along with experience in advertising, events, sponsorships and more.
Monday 28th March 2022: Global Leaders combine to provide pre-race COVID testing of UAE Team Emirates
Randox, a world leader in Health Diagnostics has been announced as the Official Supplier of UAE Team Emirates. The two-time winners of cycling’s most prestigious prize, the Tour de France.
The agreement will see UAE Team Emirates utilise the Vivalytic, a point of care platform brought to the market by Randox Laboratories and Bosch Healthcare Solutions to test riders and the wider support staff for COVID prior to upcoming races and tours.
The Bosch Vivalytic brings innovation to the Molecular Diagnostic testing market. A fully automated, sample to point of care diagnostic machine with the full molecular workflow consolidated into one small benchtop platform.
The ethos of improving healthcare which drove Randox Managing Director Dr Peter Fitzgerald to start the company in the 1980s is clearly reciprocated by their new partners. From their initiation into the top tier of professional cycling in 2017, UAE Team Emirates have had the aim of representing an entire nation, the UAE, and promoting a healthy lifestyle through cycling.
Team UAE Emirates are the newest addition to Randox’s growing portfolio of elite sporting sponsorships, which includes; GB Olympic and Paralympic teams, Sheffield United Football Club, Olimpia Milano and the Aintree Randox Grand National. The first endeavour into the United Arab Emirates sporting industry comes as no surprise as Randox have been providing UAE Hospitals, Universities and Veterinary centres with their broad range of products and services, offering a comprehensive insight into patient diagnosis to facilitate more effective disease management and treatment for a number of years.
Giulio Saule, Randox International Sales Manager stated:
“For a Global Company such as Randox it is an honour to be supplier of COVID tests to UAE Team Emirates, a team that in both 2020 and 2021 won the Tour de France and ended in the top 5 of the UCI Teams Ranking. The effort of the team in talents looks exactly the same as Randox effort in bringing innovative technologies on the market. This cooperation then brings Randox in one of the elite sports where surely there may be different horizons than COVID.”
Andrea Agostini, chief operating officer UAE Team Emirates stated:
We have paid a lot of attention against this virus since the beginning. For us the health of our members is a priority and to have the possibility to test them always, autonomously, during the cycling season is a big advantage.
About Team UAE
UAE Team Emirates entered the highest level of professional cycling, the World Tour, in early 2017. The team has the aim of representing an entire nation, the UAE, and promoting a healthy lifestyle linked to the use of the bicycle.
Season after season, the Emirati team has attracted a growing number of world-class riders and quality sponsors, taking them to new heights and successes in the biggest races in the world. The culmination of this growth and success has come with the victories of Tadej Pogacar in the Tour de France in 2020 and 2021.
Want to know more?
Contact us or visit UAE Team Emirates.